Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
PRUNUS Therapeutics logo — Sustainable therapeutics via synthetic biology

PRUNUS Therapeutics

Sustainable therapeutics via synthetic biology

Founded 2016 United States Chicago, United States 1 employees Biotechnology, Health Care +1

General Information

Company Name PRUNUS Therapeutics
Founded Year 2016
Location United States Chicago, United States +1
Employees 1
Industries Biotechnology, Health Care, Pharmaceutical
Social

Get notified when PRUNUS Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About PRUNUS Therapeutics

PRUNUS Therapeutics is a biotechnology startup that focuses on sustainable therapeutics via synthetic biology. Founded in 2016, the company's main platform is dedicated to the discovery and development of innovative therapeutics and diagnostics for human and animal healthcare, with a specific emphasis on sustainable cancer treatment. The company operates within the Biotechnology, Health Care, and Pharmaceutical industries.

As of now, details about the company's headquarters and its last investment are not available. PRUNUS Therapeutics presents an intriguing investment opportunity for venture capital firms interested in supporting groundbreaking advancements in the field of synthetic biology and sustainable healthcare.

Taxonomy: synthetic biology, therapeutics, diagnostics, preclinical stage, immuno-oncology, small molecules, cancer immunotherapy

No funding data available for PRUNUS Therapeutics yet.

Get notified when PRUNUS Therapeutics raises funding

PRUNUS Therapeutics Alternatives & Competitors

PRUNUS Therapeutics vs
Orogen Therapeutics
Orogen Therapeutics United States

Based in Woburn, Massachusetts, we create groundbreaking therapeutics with pioneering technologies.

Series A
17 employees
PRUNUS Therapeutics vs
Tempest Therapeutics
Tempest Therapeutics

Pioneering the future of cancer treatment with innovative small molecule therapeutics that enhance a...

Post Ipo Equity
11-50 employees
Biotechnology, Health Care
PRUNUS Therapeutics vs
CV Therapeutics
CV Therapeutics United States

CV Therapeutics, Inc. is a biopharmaceutical company headquartered in Palo Alto, CA. Focused on the...

Undisclosed
468 employees
Biotechnology, Health Care

FAQ About PRUNUS Therapeutics

Sustainable therapeutics via synthetic biology
PRUNUS Therapeutics was founded in 2016.
PRUNUS Therapeutics is headquartered in Chicago, United States.
PRUNUS Therapeutics operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
PRUNUS Therapeutics has approximately 1 employees.
Top alternatives and competitors to PRUNUS Therapeutics include Orogen Therapeutics, Tempest Therapeutics, CV Therapeutics, PIC Therapeutics, Iyuda Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PRUNUS Therapeutics and Orogen Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors PRUNUS Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy